Showing results (651-660 of 735) with videos related to

Sort By:
Pageof 74
Transplantation Proceedings|March 19, 2019
Remarkable Improvement of Cardiac Function After Pre-emptive Kidney Transplant in a Patient With Severe Mitral Regurgitation Accompanied by Low Cardiac Function: A Case ReportR Oki, S Hidaka, H Moriya, et al.
Brain & Development|July 1, 1996
A cloverleaf skull syndrome probably of Beare-Stevenson type associated with Chiari malformationS Ito, K Matsui, E Ohsaki, et al.
Leukemia|November 6, 2013
CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cellsM Takahashi, Y Matsuoka, K Sumide, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1987
Demonstration of up-regulated IL 2 receptor expression on an in vitro cloned BCL1 sublineK Nakanishi, T Hashimoto, K Hiroishi, et al.
Japanese Journal of Cancer Research : Gann|December 26, 2001
Phage display cloning and characterization of monoclonal antibody genes and recombinant Fab fragment against the CD98 oncoproteinK Itoh, K Inoue, K Hirooka, et al.
Rheumatology (Oxford, England)|February 21, 2007
Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseasesY Kamata, Y Takahashi, M Iwamoto, et al.
The American Journal of Surgical Pathology|March 21, 2001
Prognostic significance of pulmonary lymphangioleiomyomatosis histologic scoreK Matsui, M B Beasley, W K Nelson, et al.
Transplantation Proceedings|May 9, 2012
Stimulation of liver regeneration after hepatectomy in mice by injection of bone marrow mesenchymal stem cells via the portal veinM Kaibori, Y Adachi, T Shimo, et al.
Arerugi = [Allergy]|July 1, 1996
[Correlation of interleukin-2 (IL-2) responsiveness by egg white-stimulated lymphocytes with hen egg oral provocation test in atopic children]T Noma, I Yoshizawa, K Kou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI)I Sekine, Y Nishiwaki, K Noda, et al.
Pageof 74